1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin CombinationNutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic diseaseRecruitingPhase 42026-04-17NCT06862739